KalVista Pharmaceuticals
KALV
#6541
Rank
A$0.88 B
Marketcap
$17.71
Share price
-5.39%
Change (1 day)
4.10%
Change (1 year)

Earnings for KalVista Pharmaceuticals (KALV)

Earnings in 2025 (TTM): -A$0.27 Billion

According to KalVista Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.29 Billion a decrease over its 2023 earnings that were of -A$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for KalVista Pharmaceuticals from 2014 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.27 Billion-6.59%
2024 -A$0.29 Billion43.36%
2023 -A$0.2 Billion12.87%
2022 -A$0.18 Billion20.62%
2021 -A$0.15 Billion79.87%
2020 -A$80.78 Million14.01%
2019 -A$70.86 Million98.95%
2018 -A$35.62 Million3.41%
2017 -A$34.44 Million-13.11%
2016 -A$39.64 Million1.3%
2015 -A$39.14 Million92.7%
2014 -A$20.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.24 Billion-16.65%๐Ÿ‡บ๐Ÿ‡ธ USA